咳止めおよび風邪薬の世界市場レポート 2024

咳止めおよび風邪薬の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.1%の年間複合成長率（CAGR）で1,043億1,000万米ドルに成長すると予想されます。予測される成長は、電子タバコ/電子タバコの増加、肥満率の増加、未診断人口の増加、および政府の取り組みによるものです。主な動向には、喘息用のプロバイオティクス、先進的な気管支拡張薬、新製品の発売、市場提携、個別化医療、エアロゾル呼吸器薬、ジェネリック呼吸器薬、COPDの併用療法が含まれます。

咳止めおよび風邪薬市場の成長は、予測期間におけるアレルギーの発生率の増加によって促進されると予想されます。花粉、ほこり、カビ、ペットのふけによって引き起こされるものを含む呼吸器アレルギーは、屋外および屋内の空気の汚染により増加傾向にあります。 咳止めおよび風邪薬は、咳や呼吸器の問題として現れるアレルギーに対処するためによく使用されます。たとえば、欧州アレルギー・臨床免疫学会は、2025年までに欧州連合内の3人に1人がアレルギーに罹患すると予測しています。この呼吸器アレルギーの急増により、咳止めおよび風邪薬の需要が高まり、市場の成長にプラスの影響を与えると予想されます。

咳止めおよび風邪薬市場の成長は、高齢者人口の増加によってさらに加速されることが予想されます。 65歳以上の高齢者は免疫力が低下していることが多く、咳や風邪などの呼吸器感染症にかかりやすくなります。この脆弱性の高まりにより、咳や風邪の治療薬に対する需要が増大しています。 2022年 10月の世界保健機関（WHO）の報告書によると、世界の6人に1人が2030年までに60歳以上になると予想されています。世界の80歳以上の人口は、2020年から2020年までの間に4億2,600万人増加すると予測されています。 2050年。高齢化に向けた人口動態の変化は、咳止めおよび風邪薬市場の成長の重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の咳止めおよび風邪薬市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 気管支拡張薬
• 抗コリン作用
• 肺高血圧症治療薬
• 世界の咳止めおよび風邪薬市場、薬剤タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗ヒスタミン薬
• 去痰薬
• 気管支拡張薬
• 鼻詰まり除去剤
• 抗生物質
• その他のタイプ
• 世界の咳止めおよび風邪薬市場、投与タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口シロップ
• 錠剤/丸薬
• 点鼻薬
• トローチ
• その他の投与量タイプ
• 世界の咳止めおよび風邪薬市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• ドラッグストア

第7章 地域および国の分析

• 世界の咳止めおよび風邪薬市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の咳止めおよび風邪薬市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 咳止めおよび風邪薬市場の競合情勢
• 咳止めおよび風邪薬市場の企業プロファイル
  • Johnson &Johnson
  • GlaxoSmithKline plc
  • Procter &Gamble
  • Bayer AG
  • Reckitt Benckiser Group plc

第31章 その他の大手および革新的な企業

• Novartis AG
• Perrigo Company
• Sun Pharmaceutical Industries Ltd.
• Prestige Consumer Healthcare
• Blackmores Limited
• AFT Pharmaceuticals
• Dexa Medica
• Glenmark Pharmaceuticals Limited
• Wockhardt Ltd
• Apnar Pharma LP
• Hanmi Pharmaceutical
• Cipla Limited
• Aurobindo Pharma Limited
• KYORIN Holdings, Inc
• Nichi-Iko Pharmaceutical Co., Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Cold and cough preparations encompass medications designed to alleviate symptoms associated with these conditions. These drugs target receptors where the infecting virus attaches, countering the receptor's action, eradicating viral infection, and reducing congestion by breaking down mucus and expanding constricted bronchioles.

Primary drug categories in cold and cough preparations consist of antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and other similar treatments. Antihistamines mitigate histamine's effects and are commonly used to address allergies. Varieties include bronchodilators, anticholinergic, and pulmonary antihypertensives. These medications are available in various forms such as oral syrups, tablets, nasal drops, lozenges, and others. Distribution occurs through hospital pharmacies, retail pharmacies, drug stores, and similar channels.

The cold and cough preparations market research report is one of a series of new reports from The Business Research Company that provides cold and cough preparations market statistics, including cold and cough preparations industry global market size, regional shares, competitors with a cold and cough preparations market share, detailed cold and cough preparations market segments, market trends and opportunities, and any further data you may need to thrive in the cold and cough preparations industry. This cold and cough preparations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cough and cold preparations market size has grown strongly in recent years. It will grow from $80.96 billion in 2023 to $85.36 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. Historical growth can be attributed to several factors, including the increased prevalence of respiratory diseases, higher rates of tobacco smoking, global warming, robust economic growth in emerging markets, and an upsurge in healthcare expenditure.

The cough and cold preparations market size is expected to see strong growth in the next few years. It will grow to $104.31 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. Forecasted growth stems from the rise in e-cigarettes/vaping, increasing obesity rates, a sizable undiagnosed population, and government initiatives. Major trends include probiotics for asthma, advanced bronchodilators, new product launches, market collaborations, personalized medicines, aerosol respiratory drugs, generic respiratory drugs, and combination therapy for COPD.

The growth of the cough and cold preparations market is anticipated to be fueled by the rising incidence of allergies in the forecast period. Respiratory allergies, including those triggered by pollen, dust, mold, and pet dander, are on the ascent due to contaminated outdoor and indoor air. Cough and cold preparations are commonly used to address allergies that manifest as coughs and respiratory issues. For example, the European Academy of Allergy and Clinical Immunology projects that by 2025, one in every three people in the European Union will be affected by allergies. This surge in respiratory allergies is expected to drive demand for cough and cold preparations, positively influencing market growth.

The growth of the cough and cold preparations market is expected to receive a boost from the increasing geriatric population. The elderly, aged 65 and older, often have weaker immune systems, making them more susceptible to respiratory infections such as coughs and colds. This heightened vulnerability contributes to a greater demand for cough and cold remedies. According to a report by the World Health Organization (WHO) in October 2022, one in six people globally is expected to be 60 or older by 2030. The worldwide population of individuals aged 80 or older is projected to increase by 426 million between 2020 and 2050. This demographic shift toward an aging population is a significant driver of the growth in the cough and cold preparations market.

Advancements in technologies are playing a pivotal role in shaping the global pharmaceutical sector, and this impact extends to cold and cough preparations. As outlined in a global life sciences report by Deloitte, various cutting-edge technologies are driving the life sciences sector, including the pharmaceutical domain. Some of these transformative technologies include AI, robotic automation, the Internet of Medical Things (IoMT), blockchain, DIY diagnostics, virtual care, mobility in drug delivery and clinical trials, genomics, next-generation therapies, cloud computing, Real-World Evidence (RWE), and data-driven precision medicine. AI technology is being harnessed for diagnoses, treatment planning, patient monitoring, and drug discovery. The IoMT is facilitating the emergence of new business models and enhancing customer experiences. Biomarkers, which are biological indicators objectively measured and evaluated for various processes, are increasingly being utilized in the drug development process to expedite product launches.

Major companies in the cough and cold preparations market are responding to these technological advancements by developing new products, such as herbal cough syrups, to cater to larger customer bases, drive more sales, and increase revenue. Herbal cough syrups are liquid formulations made from natural or plant-based ingredients, typically incorporating herbs, botanical extracts, and other organic compounds. These products aim to alleviate symptoms of coughs and colds. For example, Dexa Medica, an Indonesia-based pharmaceutical company, launched Herbacough in May 2021. Herbacough is a herbal cough syrup known for its unique qualities, including the absence of side effects or addictive tendencies. Positioned as an effective treatment for various types of coughs, Herbacough boasts benefits such as soothing sore throats, easing breathing, warming the respiratory tract, and relieving different forms of coughs. The product employs the latest fractionation technology, an extraction method isolating a specific active substance, reconyl, making it a safe and efficient remedy for cough and sore throat issues.

The cold and cough preparations market is subject to regulatory oversight by authorities, such as the Food and Drug Administration (FDA) in the United States. An example of regulatory action is the FDA's restriction on the use of codeine in children. Codeine, although approved for pain and cough treatment, poses serious risks, including the potential for slowed or difficult breathing, and can be fatal. The FDA has recognized a higher risk of these adverse effects in children under the age of 12, leading to restrictions on the use of codeine even in some older children. Single-ingredient codeine is FDA-approved solely for use in adults. Additionally, the FDA recommends against the use of codeine in breastfeeding mothers due to the potential harm it may pose to their infants. This regulatory intervention reflects a commitment to ensuring the safety of pharmaceutical products, especially those intended for vulnerable populations such as children and breastfeeding mothers.

Major companies operating in the cough and cold preparations market report are Johnson & Johnson, GlaxoSmithKline PLC, Procter & Gamble, Bayer AG, Reckitt Benckiser Group PLC, Novartis AG, Perrigo Company, Sun Pharmaceutical Industries Ltd., Prestige Consumer Healthcare, Blackmores Limited, AFT Pharmaceuticals, Dexa Medica, Glenmark Pharmaceuticals Limited, Wockhardt Ltd., Apnar Pharma LP, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd. , China National Pharmaceutical Group Co., Ltd., Shanghai Anovent Pharma, Shanghai Acebright Pharmaceuticals Group Co., Ltd., China Meheco Group Co., Ltd. , Merck & Co, Abbott Laboratories, Boehringer Ingelheim, Roche Holding AG, Vectura Group, Pfizer, Mylan, Teva Pharmaceutical Industries Ltd., Sanofi, W. K. Buckley Limited, BENYLIN, Sanfer, PROBIOMED, PiSA, EMS Pharma, Hypermarcas, Ache, Eurofarma, Biolab Farmaceuticad, Cristalia, Libbs, AstraZeneca, Neopharma, Regal Pharmaceuticals, Adcock Ingram, Aspen Pharmacare

North America was the largest region in the cold and cough preparation market share in 2023. Middle East is expected to be the fastest-growing region in the global cough and cold preparations market during the forecast period. The regions covered in the cough and cold preparations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cough and cold preparations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The cold and cough preparations market consists of sales of dextromethorphan, guaifenesin, and phenylephrine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cough And Cold Preparations Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cough and cold preparations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cough and cold preparations? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cough and cold preparations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drug Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Antibiotics; Other Drug Types.
• 2) By Dosage Type: Oral Syrups; Tablets/Pills; Nasal Drops; Lozenges; Other Dosage Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Other Distribution Channels
• Companies Mentioned: Johnson & Johnson; GlaxoSmithKline plc; Procter & Gamble; Bayer AG; Reckitt Benckiser Group plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cough And Cold Preparations Market Characteristics

3. Cough And Cold Preparations Market Trends And Strategies

4. Cough And Cold Preparations Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Cough And Cold Preparations Market Size and Growth

• 5.1. Global Cough And Cold Preparations Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Cough And Cold Preparations Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Cough And Cold Preparations Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cough And Cold Preparations Market Segmentation

• 6.1. Global Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Bronchodialators
• Anticholinergic
• Pulmonary Antihypertensives
• 6.2. Global Cough And Cold Preparations Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antihistamines
• Expectorants
• Bronchodilators
• Decongestants
• Antibiotics
• Other Types
• 6.3. Global Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral Syrups
• Tablets/Pills
• Nasal Drops
• Lozenges
• Other Dosage Types
• 6.4. Global Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores

7. Cough And Cold Preparations Market Regional And Country Analysis

• 7.1. Global Cough And Cold Preparations Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Cough And Cold Preparations Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cough And Cold Preparations Market

• 8.1. Asia-Pacific Cough And Cold Preparations Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cough And Cold Preparations Market

• 9.1. China Cough And Cold Preparations Market Overview
• 9.2. China Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cough And Cold Preparations Market

• 10.1. India Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cough And Cold Preparations Market

• 11.1. Japan Cough And Cold Preparations Market Overview
• 11.2. Japan Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cough And Cold Preparations Market

• 12.1. Australia Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cough And Cold Preparations Market

• 13.1. Indonesia Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cough And Cold Preparations Market

• 14.1. South Korea Cough And Cold Preparations Market Overview
• 14.2. South Korea Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cough And Cold Preparations Market

• 15.1. Western Europe Cough And Cold Preparations Market Overview
• 15.2. Western Europe Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cough And Cold Preparations Market

• 16.1. UK Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cough And Cold Preparations Market

• 17.1. Germany Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cough And Cold Preparations Market

• 18.1. France Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cough And Cold Preparations Market

• 19.1. Italy Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cough And Cold Preparations Market

• 20.1. Spain Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cough And Cold Preparations Market

• 21.1. Eastern Europe Cough And Cold Preparations Market Overview
• 21.2. Eastern Europe Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cough And Cold Preparations Market

• 22.1. Russia Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cough And Cold Preparations Market

• 23.1. North America Cough And Cold Preparations Market Overview
• 23.2. North America Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cough And Cold Preparations Market

• 24.1. USA Cough And Cold Preparations Market Overview
• 24.2. USA Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cough And Cold Preparations Market

• 25.1. Canada Cough And Cold Preparations Market Overview
• 25.2. Canada Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cough And Cold Preparations Market

• 26.1. South America Cough And Cold Preparations Market Overview
• 26.2. South America Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cough And Cold Preparations Market

• 27.1. Brazil Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cough And Cold Preparations Market

• 28.1. Middle East Cough And Cold Preparations Market Overview
• 28.2. Middle East Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cough And Cold Preparations Market

• 29.1. Africa Cough And Cold Preparations Market Overview
• 29.2. Africa Cough And Cold Preparations Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cough And Cold Preparations Market Competitive Landscape And Company Profiles

• 30.1. Cough And Cold Preparations Market Competitive Landscape
• 30.2. Cough And Cold Preparations Market Company Profiles
  • 30.2.1. Johnson & Johnson
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. GlaxoSmithKline plc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Procter & Gamble
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Reckitt Benckiser Group plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Cough And Cold Preparations Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Perrigo Company
• 31.3. Sun Pharmaceutical Industries Ltd.
• 31.4. Prestige Consumer Healthcare
• 31.5. Blackmores Limited
• 31.6. AFT Pharmaceuticals
• 31.7. Dexa Medica
• 31.8. Glenmark Pharmaceuticals Limited
• 31.9. Wockhardt Ltd
• 31.10. Apnar Pharma LP
• 31.11. Hanmi Pharmaceutical
• 31.12. Cipla Limited
• 31.13. Aurobindo Pharma Limited
• 31.14. KYORIN Holdings, Inc
• 31.15. Nichi-Iko Pharmaceutical Co., Ltd

32. Global Cough And Cold Preparations Market Competitive Benchmarking

33. Global Cough And Cold Preparations Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cough And Cold Preparations Market

35. Cough And Cold Preparations Market Future Outlook and Potential Analysis

• 35.1 Cough And Cold Preparations Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Cough And Cold Preparations Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Cough And Cold Preparations Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer